Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Recent Patents on DNA & Gene Sequences|December 17, 2008
ErbB4 and its isoforms: patentable drug targets?Ilkka Paatero, Klaus Elenius
Scientific Reports|August 18, 2021
Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxiaJuho Heliste, Anne Jokilammi, Katri Vaparanta, et al.
Iscience|January 22, 2026
Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancersDeepankar Chakroborty, Katri Vaparanta, Bishwa Ghimire, et al.
Molecular Biology of the Cell|November 22, 2018
ErbB4 tyrosine kinase inhibition impairs neuromuscular development in zebrafish embryosIlkka Paatero, Ville Veikkolainen, Matias Mäenpää, et al.
BMC Cardiovascular Disorders|October 22, 2018
Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic targetJuho Heliste, Anne Jokilammi, Ilkka Paatero, et al.
Journal of Molecular and Cellular Cardiology|December 24, 2019
Genetic and functional implications of an exonic TRIM55 variant in heart failureJuho Heliste, Himanshu Chheda, Ilkka Paatero, et al.
The Journal of Biological Chemistry|June 27, 2014
Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary glandIlkka Paatero, Tiffany N Seagroves, Katri Vaparanta, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2008
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoformsMaria Sundvall, Anna Korhonen, Ilkka Paatero, et al.
Pageof 11